tiprankstipranks

David E. Wheadon Insider Profile

4 Followers
David E. Wheadon, Director at Assertio Therapeutics, holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX), holds 14.75K shares in Vaxart (Ticker: VXRT), holds 35.69K shares in Sotera Health (Ticker: SHC).
tipranks
David E. Wheadon

David E. Wheadon
Assertio Therapeutics (ASRT)
Director

Not Ranked
David E. Wheadon has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$698K
56.31%
42.15%
1.54%
A breakdown of David E. Wheadon's holdings

Insider Roles

Sotera Health
(SHC)
Director
Assertio Therapeutics
(ASRT)
Director
Vaxart
(VXRT)
Director
Roles that David E. Wheadon holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by David E. Wheadon

David E. Wheadon's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Assertio Therapeutics
Sep 29, 2020
Director
Uninformative Buy
$294.42K
Vaxart
Aug 01, 2023
Director
Uninformative Buy
$10.74K
KRTX
Karuna Therapeutics
Mar 18, 2024
Uninformative Sell
326.70K
$0.00
Sotera Health
May 31, 2023
Director
Uninformative Buy
$393.31K
CCXI
ChemoCentryx
List of latest transactions for each holding click on a transaction to see David E. Wheadon's performance on stock

David E. Wheadon insider profile FAQ

What is the percentage of profitable transactions made by David E. Wheadon?
The percentage of profitable transactions made by David E. Wheadon is ―.
    What is the average return per transaction made by David E. Wheadon?
    The average return per transaction made by David E. Wheadon is ―.
      What stocks does David E. Wheadon hold?
      David E. Wheadon holds: ASRT, VXRT, KRTX, SHC, CCXI stocks.
        What was David E. Wheadon’s latest transaction?
        David E. Wheadon latest transaction was an Uninformative Sell of $326.70K.
          What was David E. Wheadon's most profitable transaction?
          David E. Wheadon’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is David E. Wheadon's role in Assertio Therapeutics?
            David E. Wheadon's role in Assertio Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.